Portfolio comparison
Genentech Inc vs Curevac SE
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Genentech Inc
Patents indexed
13
Year range
1982 – 2017
Most recent
2017
biotechpharmaceuticalgene_editinghealthcareoncology
Top Patents13 enriched
US 4816567· 1989
Making Hybrid Antibodies from Different Animals
US 7527791· 2009
How Engineered Antibodies Target TGF-beta Proteins to Fight Cancer
US 6054297· 2000
How to Redesign Mouse Antibodies for Safe Use in Humans
Activity by Decade
1980s2
2000s8
2010s3
Company B
Curevac SE
Patents indexed
2
Year range
2024
Most recent
2024
biotechpharmaceuticaloncologygene_editingimmunotherapy
Top Patents2 enriched
US 12048738· 2024
Using mRNA to Teach the Body to Fight Prostate Cancer
US 12083190· 2024
How an mRNA Vaccine Teaches Your Body to Fight Rabies
Activity by Decade
2020s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.